Louise Slaughter: “may I inquire from my colleague if he is ready to yield back, then I will close.”

The FDA needs clear statutory direction to take aggressive action against this resistance.

Fighting antimicrobial resistance is a key component of this kind of populationwide prevention strategy.

To say that I am completely appalled and embarrassed by that number is an understatement.

I strongly urge him to do that. If legislation is necessary, we are prepared to act.